Probiotic administration reduces intestinal leakage by, among others, affecting intestinal immunoregulation and anti-inflammatory effects (for example, an increase in sIgA production), anti-inflammatory effects, strengthening the epithelial barrier (for example, an increase in the synthesis of mucin and short-chain fatty acids (SCFAs), and the production of bacteriocins, which limit the growth of pathogenic microorganisms (for example, defensin) [8, 133, 134]
Its distinctive origin within mitochondrial DNA continues to make MOTS-c a valuable research peptide for exploring the mechanisms that regulate mitochondrial health and cellular resilience
In some circumstances, yes, and the 2026 guideline explicitly moves in that direction for familial hypercholesterolaemia, markedly raised LDL-C, or strong family history
Too early to see the effects although I believe I am eating less This place is great